Mcprf Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MCPRF
MCPRF has four approved drugs.
Summary for Mcprf
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Mcprf
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mcprf | CHOLINE C-11 | choline c-11 | INJECTABLE;INTRAVENOUS | 203155-001 | Sep 12, 2012 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mcprf | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 203605-001 | Jun 28, 2013 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mcprf | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203612-001 | Aug 5, 2013 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mcprf | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203321-001 | Feb 25, 2013 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
